MUMBAI, India, Aug. 31 -- Intellectual Property India has published a patent application (202621072045 A) filed by Indian Institute Of Technology Indore on June 10, 2026, for An Immunomodulatory Peptide For Inhibiting Il-33-Mediated Inflammatory Signaling And Method Thereof.
Inventors include Dr. Mirza S Baig; Sk Rameej Raja; and Niharika.
The application for the patent was published on August 28, 2026, under issue no. 35/2026.
Abstract: ABSTRACT AN IMMUNOMODULATORY PEPTIDE FOR INHIBITING IL-33-MEDIATED INFLAMMATORY SIGNALING AND METHOD THEREOF The present invention provides a novel immunomodulatory peptide that has been specifically developed as a therapeutic agent for the treatment, prevention, and long-term management of allergic and ...